Lv4
420 积分 2021-10-08 加入
Author Correction: Neoadjuvant immunotherapy for dMMR and pMMR colorectal cancers: therapeutic strategies and putative biomarkers of response
8天前
已完结
Neoadjuvant immunotherapy for dMMR and pMMR colorectal cancers: therapeutic strategies and putative biomarkers of response
8天前
已完结
NRG Oncology International Consensus Contouring Atlas on Target Volumes and Dosing Strategies for Dose-Escalated Pancreatic Cancer Radiotherapy
9天前
已完结
Ovarian cancer-derived IL-4 promotes immunotherapy resistance
10天前
已完结
Reirradiation with stereotactic body radiotherapy for primary or secondary lung malignancies: Tumor control probability and safety analyses
11天前
已完结
Randomized phase III study comparing re-irradiation stereotactic body radiotherapy and conventional radiotherapy for painful spinal metastases: Japan Clinical Oncology Group study JCOG2211 (RESCORE study)
23天前
已完结
Randomized phase III study comparing re-irradiation stereotactic body radiotherapy and conventional radiotherapy for painful spinal metastases: Japan Clinical Oncology Group study JCOG2211 (RESCORE study)
23天前
已关闭
Robust localization of poorly visible tumor in fiducial free stereotactic body radiation therapy
24天前
已完结
Deep match: A zero-shot framework for improved fiducial-free respiratory motion tracking
24天前
已完结
Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3 trial
1个月前
已完结
MiR-126-3p suppresses the growth, migration and invasion of NSCLC via targeting CCR1
皖公网安备34019202002308
